Selting Elected President-Elect
of Veterinary Cancer Society
|Dr. Kim Selting
Kim Selting, DVM, MS, DACVIM (oncology), DACVR (radiation oncology), assistant professor of oncology at the MU College of Veterinary Medicine, has been elected president-elect of the Veterinary Cancer Society. Selting was installed as president-elect during the 2014 Veterinary Cancer Society annual conference in St. Louis.
Formed in 1976, the VCS has a membership of nearly 1,000 people, including specialists in medical, surgical and radiation oncology, internists, pathologists, pharmacologists and general practitioners worldwide. The nonprofit’s mission is to disseminate information to members, inspire collaboration by connecting individuals with diverse interests in oncology, and foster awareness of scientific information among the public, cancer care providers and investigators.
Selting will serve the VCS executive committee for two years as president-elect before becoming president. After two years in that role, she will spend another two years on the committee as the past president.
She said the committee has recently made some positive changes to the structure of its annual conference, and she hopes to continue modifying the meeting to ensure that it is as productive and informative as possible for attendees. The conference is one of the largest veterinary oncology meetings in the world.
Selting’s additional goals include pursuing ways to identify standards of common practice among members and boosting involvement by less-represented groups of care providers.
“We are a cross-specialty, international organization, and I would like to find ways to better incorporate our international colleagues as well as encouraging even more participation by related specialties, such as surgery, radiation and pathology,” Selting said.
Selting has been involved in the VCS since becoming a member in 1994. She is part of the organization’s Veterinary Cooperative Oncology Group, a group of members who share an interest in veterinary and comparative oncology. She previously served as the group’s president and was also a member-at-large on the executive committee for three years. This year she was co-chair of the annual meeting.
Selting, who joined the CVM faculty in 2002, completed her doctor of veterinary medicine degree and a master’s degree in clinical sciences at Colorado State University. She is a diplomate of the American College of Veterinary Internal Medicine in the specialty of oncology and of the American College of Veterinary Radiology in radiation oncology.
Her clinical research interests include biomarkers of cancer, particularly thymidine kinase and vitamin D, new cancer treatments including radioactive substances, and detection of cancer by breath analysis. Among tumor types, Selting is interested specifically in the treatment of lung and bone cancer.
In addition to her teaching and clinical duties at the Veterinary Medical Teaching Hospital, Selting travels twice weekly to Mizzou Animal Cancer Care, a satellite clinic in Wentzville where radiation therapy is offered along with clinical trials of anti-cancer drugs.
Return to News and Events home